Abstract
Purpose
The aim of this study was to assess the effectiveness of Manuka honey ointment and dressings in the conservative management of exomphalos major (EM).
Methods
A retrospective review of five patients with EM who underwent non-operative management with Manuka honey ointments and dressings was carried out to assess the time to complete epithelialisation, time to full feeds, hospital stay, adverse effects, complications and outcome.
Results
The skin epithelialisation over the EM sac was achieved in a median of 63 days (48–119). The median time to full enteral feed was 13 days (3–29). The median hospital stay was 66 days (21–121). No adverse effects were noted related to Manuka honey. Three patients had pulmonary hypoplasia requiring prolonged hospitalization; one of those died with respiratory complications at home after achieving complete epithelialisation. The follow-up was a median 16 months (6–22). Two patients did not require repair of the ventral hernia. One patient had ventral hernia repair at 16 months with excellent cosmesis. The remaining patient is awaiting repair.
Conclusion
This is the first description of the use of medicated Manuka honey ointment and impregnated dressings in the conservative management of EM. This treatment is safe, efficacious and promotes wound healing with favorable outcome.
Similar content being viewed by others
References
Magnusson DK (2006) Abdominal wall defects. In: Stringer MD, Oldham KT, Mouriquand PDE (eds) Pediatric surgery and urology: long-term outcomes (second edition). Cambridge University Press, pp 270–285
Pacilli M, Spitz L, Kiely EM et al (2005) Staged repair of giant omphalocele in the neonatal period. J Pediatr Surg 40:785–788
Lee SL, Todd D, Beyer TD, Kim SS et al (2006) Initial nonoperative management and delayed closure for treatment of giant omphaloceles. J Pediatr Surg 41:1846–1849
Marven S, Owen A (2008) Contemporary postnatal surgical management strategies for congenital abdominal wall defects. Semin Pediatr Surg 17(4):222–235
Mullins ME, Horowitz BZ (1999) Iatrogenic neonatal mercury poisoning from mercurochrome treatment of a large omphalocele. Clin Pediatr 38:111–112
Cosman BC, Schullinger JN, Bell JJ et al (1988) Hypothyroidism caused by topical povidone-iodine in a newborn with omphalocele. J Pediatr Surg 23:356–358
Lewis N, Kolimarala V, Lander A (2010) Conservative management of exomphalos major with silver dressings: are they safe? J Pediatr Surg 45(12):2438–2439
Jull AB, Walker N, Deshpande S (2013) Honey as a topical treatment for wounds. Cochrane Database Syst Rev 28 2:CD005083
Riddle JM (1985) Dioscorides on pharmacy and medicine. University of Texas Press, Austin
Trevisanato SI (2006) Treatments for burns in the London Medical Papyrus show the first seven biblical plagues of Egypt are coherent with Santorini’s volcanic fallout. Med Hypotheses 66:193–196
Oryan A, Zaker SR (1998) Effects of topical application of honey on cutaneous wound healing in rabbits. J Vet Med Ser A 45(3):181–183
Molan PC (1999) Why honey is effective as a medicine. 1. Its use in modern medicine. Bee World 80:80–92
Molan PC (2001) Why honey is effective as medicine. 2. The scientific explanation of its effects. Bee World 82:22–40
Jull A, Walker N, Parag V, Molan P, Rodgers A, on behalf of the Honey as Adjuvant Leg Ulcer Therapy trial collaborators (2008) Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 95(2):175–182
Molan PC, Betts JA (2004) Clinical usage of honey as a wound dressing: an update. J Wound Care 13(9):353–356
Vachharajani AJ, Rao R, Keshwani S, Mathur AM (2009) Outcome of exomphalos: an institutional experience. Pediatr Surg Int 25:139–144
Russell AD, Hugo WB (1994) Antimicrobial activity and action of silver. Prog Med Chem 31:351–370
Charlsworth P, Ervine E, McCullagh M (2009) Exomphalos major: the Northern Ireland experience. Pediatr Surg Int 25:77–81
Tsakayannis DE, Zurakowski D, Lillehei CW (1996) Respiratory insufficiency at birth: a predictor for infants with omphalocele. J Pediatr Surg 31:1088–1091
Danzer E, Hendrick HL, Rintoul NE, Siegle J, Adzick NS, Panitch HB (2012) Assessment of early pulmonary abnormalities in giant omphalocele survivors. J Pediatr Surg 47:1811–1820
Arnon SS, Midura TF, Damus K, Thompson B, Wood RM, Chin J (1979) Honey and other environmental risk factors for infant botulism. J Pediatr 94(2):331–336
Molan PC, Allen KL (1996) The effects of gamma-irradiation on the antibacterial activity of honey. J Pharm Pharmacol 48(11):1206–1209
Eddy J, Gideonson M, Mack G (2008) Practical considerations of using topical honey for neuropathic diabetic foot ulcers: a review. Wis Med J 107(4):187–190
Molan P, Betts J (2008) Using honey to heal diabetic foot ulcers. Adv Skin Wound Care 21(7):313–316
Bauer L, Kohlich A, Hirschweir R, Siemann U, Ebner H, Scheiner O, Kraft D, Ebner C (1996) Food allergy to honey: pollen or bee products? Characterisation of allergenic proteins in honey by means of immunoblotting. J Allergy Clin Immunol 97(1):65–73
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nicoara, C.D., Singh, M., Jester, I. et al. Medicated Manuka honey in conservative management of exomphalos major. Pediatr Surg Int 30, 515–520 (2014). https://doi.org/10.1007/s00383-014-3490-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-014-3490-1